Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mübeccel Akdis and M Akdis.
Mübeccel Akdis
Connection Strength
7.379
M Akdis
  1. B-cell responses in allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2019 12; 19(6):632-639.
    View in: PubMed
    Score: 0.855
  2. The use of biologics for immune modulation in allergic disease. J Clin Invest. 2019 03 18; 129(4):1452-1462.
    View in: PubMed
    Score: 0.814
  3. Comparison of regulatory B cells in asthma and allergic rhinitis. Allergy. 2019 04; 74(4):815-818.
    View in: PubMed
    Score: 0.800
  4. Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens. Ann Allergy Asthma Immunol. 2018 09; 121(3):306-312.
    View in: PubMed
    Score: 0.775
  5. Modified Allergens for Immunotherapy. Curr Allergy Asthma Rep. 2018 02 16; 18(2):9.
    View in: PubMed
    Score: 0.755
  6. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy. Curr Opin Immunol. 2017 Oct; 48:74-81.
    View in: PubMed
    Score: 0.732
  7. Role of Regulatory Cells in Oral Tolerance. Allergy Asthma Immunol Res. 2017 Mar; 9(2):107-115.
    View in: PubMed
    Score: 0.706
  8. T-cell tolerance to inhaled allergens: mechanisms and therapeutic approaches. Expert Opin Biol Ther. 2008 Jun; 8(6):769-77.
    View in: PubMed
    Score: 0.385
  9. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
    View in: PubMed
    Score: 0.057
  10. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020 10; 75(10):2445-2476.
    View in: PubMed
    Score: 0.057
  11. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
    View in: PubMed
    Score: 0.056
  12. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021 02; 76(2):510-532.
    View in: PubMed
    Score: 0.056
  13. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2021 02; 76(2):533-550.
    View in: PubMed
    Score: 0.056
  14. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020 10; 75(10):2503-2541.
    View in: PubMed
    Score: 0.056
  15. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
    View in: PubMed
    Score: 0.056
  16. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020 07; 75(7):1564-1581.
    View in: PubMed
    Score: 0.056
  17. Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13. Allergy. 2019 12; 74(12):2534-2537.
    View in: PubMed
    Score: 0.052
  18. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid. J Allergy Clin Immunol. 2019 06; 143(6):2190-2201.e9.
    View in: PubMed
    Score: 0.050
  19. Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma. Am J Respir Crit Care Med. 2018 12 15; 198(12):1490-1499.
    View in: PubMed
    Score: 0.050
  20. Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells. J Allergy Clin Immunol. 2019 05; 143(5):1892-1903.
    View in: PubMed
    Score: 0.050
  21. Intralymphatic Immunotherapy: Update and Unmet Needs. Int Arch Allergy Immunol. 2019; 178(2):141-149.
    View in: PubMed
    Score: 0.050
  22. Chronic rhinosinusitis: pathogenesis, therapy options, and more. Expert Opin Pharmacother. 2018 11; 19(16):1805-1815.
    View in: PubMed
    Score: 0.049
  23. Precision/Personalized Medicine in Allergic Diseases and Asthma. Arch Immunol Ther Exp (Warsz). 2018 Dec; 66(6):431-442.
    View in: PubMed
    Score: 0.049
  24. Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. J Allergy Clin Immunol. 2019 04; 143(4):1403-1415.
    View in: PubMed
    Score: 0.049
  25. The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies. Expert Rev Respir Med. 2018 09; 12(9):733-743.
    View in: PubMed
    Score: 0.049
  26. Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis. Clin Transl Allergy. 2018; 8:22.
    View in: PubMed
    Score: 0.048
  27. Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018 08; 142(2):665-668.e8.
    View in: PubMed
    Score: 0.047
  28. A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells. Bioconjug Chem. 2018 02 21; 29(2):382-389.
    View in: PubMed
    Score: 0.047
  29. Guidelines for the use of flow cytometry and cell sorting in immunological studies. Eur J Immunol. 2017 10; 47(10):1584-1797.
    View in: PubMed
    Score: 0.046
  30. Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol. 2018 07; 142(1):178-194.e11.
    View in: PubMed
    Score: 0.046
  31. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017 Nov; 140(5):1250-1267.
    View in: PubMed
    Score: 0.046
  32. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017 07; 278(1):219-236.
    View in: PubMed
    Score: 0.045
  33. Exposure to nonmicrobial N-glycolylneuraminic acid protects farmers' children against airway inflammation and colitis. J Allergy Clin Immunol. 2018 01; 141(1):382-390.e7.
    View in: PubMed
    Score: 0.045
  34. Computational analysis of multimorbidity between asthma, eczema and rhinitis. PLoS One. 2017; 12(6):e0179125.
    View in: PubMed
    Score: 0.045
  35. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 2018 01; 141(1):300-310.e11.
    View in: PubMed
    Score: 0.044
  36. The relationship of serum vitamins A, D, E and LL-37 levels with allergic status, tonsillar virus detection and immune response. PLoS One. 2017; 12(2):e0172350.
    View in: PubMed
    Score: 0.044
  37. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017 02; 139(2):388-399.
    View in: PubMed
    Score: 0.044
  38. Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organ J. 2017; 10(1):6.
    View in: PubMed
    Score: 0.044
  39. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016 Feb; 137(2):358-68.
    View in: PubMed
    Score: 0.041
  40. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med. 2009 Nov 23; 206(12):2701-15.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.